Zeitschriftenartikel zum Thema „Lung and breast/ovarian cancer“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Machen Sie sich mit Top-50 Zeitschriftenartikel für die Forschung zum Thema "Lung and breast/ovarian cancer" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Sehen Sie die Zeitschriftenartikel für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.
Prat, Aleix, Barbara Adamo, Cheng Fan, Maria Vidal, Patricia Galvan, Enriqueta Felip, Jose Maria Del Campo, Josep Tabernero und Javier Cortes. „Molecular identification of basal-like breast cancer through genomic analyses across five cancer types.“ Journal of Clinical Oncology 31, Nr. 15_suppl (20.05.2013): 1011. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.1011.
Der volle Inhalt der QuelleAchariyapota, Vuthinun, Tuenjai Chuangsuwanich und Mongkol Benjapibal. „Inflammatory Breast Cancer from Metastatic Ovarian Cancer“. Case Reports in Obstetrics and Gynecology 2016 (2016): 1–3. http://dx.doi.org/10.1155/2016/3476143.
Der volle Inhalt der QuelleR., Abhirup H., Priyanka Kenchetty und Aishwarya K. Chidananda. „Breast ovarian cancer syndrome“. International Surgery Journal 8, Nr. 8 (28.07.2021): 2454. http://dx.doi.org/10.18203/2349-2902.isj20213144.
Der volle Inhalt der QuelleAbu-Tineh, Mohammad, Hind Elmalik und Mohamed A. Yassin. „Metastatic Ovarian Cancer Presenting as Inflammatory Breast Cancer: A Case Report“. Case Reports in Oncology 13, Nr. 2 (28.07.2020): 867–74. http://dx.doi.org/10.1159/000508358.
Der volle Inhalt der QuelleBacalbasa, Nicolae, Irina Balescu, Claudia Stoica, Cristina Martac, Valentin Varlas, Andrei Voichitoiu, Lucian Pop, Sorin Petrea, Mihaela Vilcu und Iulian Brezean. „Breast metastases from ovarian cancer“. Romanian Medical Journal 69, S4 (20.06.2022): 14–16. http://dx.doi.org/10.37897/rmj.2022.s4.3.
Der volle Inhalt der QuelleArora, Nimisha, Aline Talhouk, Jessica N. McAlpine, Michael R. Law und Gillian E. Hanley. „Causes of death among women with epithelial ovarian cancer by length of survival post-diagnosis: a population-based study in British Columbia, Canada“. International Journal of Gynecologic Cancer 29, Nr. 3 (21.12.2018): 593–98. http://dx.doi.org/10.1136/ijgc-2018-000040.
Der volle Inhalt der QuelleHaan, David, Anna Bergamaschi, Yuhong Ning, William Gibb, Michael Kesling, Adriana Pitea, Maryam Nabiyouni et al. „Genome-wide 5hmC profiles to enable cancer detection and tissue of origin classification in breast, colorectal, lung, ovarian, and pancreatic cancers.“ Journal of Clinical Oncology 39, Nr. 15_suppl (20.05.2021): 3044. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.3044.
Der volle Inhalt der QuelleTkaczuk, Katherine R., Paula Rosenblatt, Ranee Mehra, Katherine A. Scilla, Nancy Tait, Katerra Caple, Binbin Yue und Ginette Serrero. „Abstract CT240: On-going phase 1A clinical trial for AG01 an first-in-class anti-progranulin (GP88) monoclonal antibody in patients with advanced malignancies“. Cancer Research 83, Nr. 8_Supplement (14.04.2023): CT240. http://dx.doi.org/10.1158/1538-7445.am2023-ct240.
Der volle Inhalt der QuelleRoland, Adjoby Cassou, Kouamé Arthur Didier, Koffi Achille, Kakou Charles, Konan Joachim, Andriamandimbison Zoly, Ahounkeng Patrick und Nshimirimana Eric. „Metastatic ovarian tumor of a lung cancer at the hospital center of Chauny (France): a case report“. International Journal of Reproduction, Contraception, Obstetrics and Gynecology 6, Nr. 10 (23.09.2017): 4682. http://dx.doi.org/10.18203/2320-1770.ijrcog20174464.
Der volle Inhalt der QuelleYurkovetsky, Zoya, Steven Skates, Aleksey Lomakin, Brian Nolen, Trenton Pulsipher, Francesmary Modugno, Jeffrey Marks et al. „Development of a Multimarker Assay for Early Detection of Ovarian Cancer“. Journal of Clinical Oncology 28, Nr. 13 (01.05.2010): 2159–66. http://dx.doi.org/10.1200/jco.2008.19.2484.
Der volle Inhalt der QuelleTkaczuk, Katherine, Paula Rosenblatt, Ranee Mehra, Katherine Scilla, Nancy Tait, Binbin Yue und Ginette Serrero. „Abstract PO5-18-06: On-going phase 1A clinical trial of A01, a chimerized monoclonal antibody to Progranulin/Glycoprotein 88 (GP88) in patients with advanced malignancy“. Cancer Research 84, Nr. 9_Supplement (02.05.2024): PO5–18–06—PO5–18–06. http://dx.doi.org/10.1158/1538-7445.sabcs23-po5-18-06.
Der volle Inhalt der QuelleCovic, Lidija, und Athan Kuliopulos. „Protease-Activated Receptor 1 as Therapeutic Target in Breast, Lung, and Ovarian Cancer: Pepducin Approach“. International Journal of Molecular Sciences 19, Nr. 8 (31.07.2018): 2237. http://dx.doi.org/10.3390/ijms19082237.
Der volle Inhalt der QuelleO'Shannessy, Daniel J., Darren W. Davis, Kenna Anderes und Elizabeth B. Somers. „Isolation of Circulating Tumor Cells from Multiple Epithelial Cancers with ApoStream® for Detecting (or Monitoring) the Expression of Folate Receptor Alpha“. Biomarker Insights 11 (Januar 2016): BMI.S35075. http://dx.doi.org/10.4137/bmi.s35075.
Der volle Inhalt der QuelleSaad, Hebatallah M., Ghada F. Tourky, Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Ahmed M. Khattab, Sohaila A. Elmasry, Abdulrahman A. Alsayegh et al. „The Potential Role of MUC16 (CA125) Biomarker in Lung Cancer: A Magic Biomarker but with Adversity“. Diagnostics 12, Nr. 12 (29.11.2022): 2985. http://dx.doi.org/10.3390/diagnostics12122985.
Der volle Inhalt der QuelleBodogai, Monica, Purevdorj Olkhanud, Yrina Rochman, Enkhzol Malchinkhuu, Katarzyna Wejksza, Ronald Gress, Charles Hesdorffer, Warren Leonard und Arya Biragyn. „Thymic stromal lymphopoietin mediates breast cancer progression and metastasis (48.9)“. Journal of Immunology 186, Nr. 1_Supplement (01.04.2011): 48.9. http://dx.doi.org/10.4049/jimmunol.186.supp.48.9.
Der volle Inhalt der QuelleKarim, Md Adnan, Abdus Samad, Utpal Kumar Adhikari, Md Ashraful Kader, Md Masnoon Kabir, Md Aminul Islam und Md Nazmul Hasan. „A Multi-Omics Analysis of Bone Morphogenetic Protein 5 (BMP5) mRNA Expression and Clinical Prognostic Outcomes in Different Cancers Using Bioinformatics Approaches“. Biomedicines 8, Nr. 2 (21.01.2020): 19. http://dx.doi.org/10.3390/biomedicines8020019.
Der volle Inhalt der QuellePinheiro, Céline, Rui M. Reis, Sara Ricardo, Adhemar Longatto-Filho, Fernando Schmitt und Fátima Baltazar. „Expression of Monocarboxylate Transporters 1, 2, and 4 in Human Tumours and Their Association with CD147 and CD44“. Journal of Biomedicine and Biotechnology 2010 (2010): 1–7. http://dx.doi.org/10.1155/2010/427694.
Der volle Inhalt der QuelleWeiss, Jessica M., Muhammad Danyal Ahsan, Emily M. Webster, Sarah R. Levi, Murtaza Qazi, Benedict Harvey, Evelyn Cantillo et al. „Hereditary breast and ovarian cancer syndrome: A misnomer?“ Journal of Clinical Oncology 41, Nr. 16_suppl (01.06.2023): 10594. http://dx.doi.org/10.1200/jco.2023.41.16_suppl.10594.
Der volle Inhalt der QuelleArason, Agnarsson, Johannesdottir, Johannsson, Hilmarsdottir, Reynisdottir und Barkardottir. „The BRCA1 c.4096+3A>G Variant Displays Classical Characteristics of Pathogenic BRCA1 Mutations in Hereditary Breast and Ovarian Cancers, But Still Allows Homozygous Viability“. Genes 10, Nr. 11 (01.11.2019): 882. http://dx.doi.org/10.3390/genes10110882.
Der volle Inhalt der QuelleErickson-Miller, Connie L., Jennifer Kirchner, Kodandaram Pillarisetti, Lone Ottesen, Yasser Mostafa Kamel, Yuan Liu, Anne-Marie Martin und Conrad Messam. „Eltrombopag Decreases Proliferation of Ovarian, Lung and Breast Tumor Cell Lines.“ Blood 114, Nr. 22 (20.11.2009): 2409. http://dx.doi.org/10.1182/blood.v114.22.2409.2409.
Der volle Inhalt der QuelleBenti, Senyi, Purushottam B. Tiwari, Dustin W. Goodlett, Leily Daneshian, Grant B. Kern, Mark D. Smith, Aykut Uren, Maksymilian Chruszcz, Linda S. Shimizu und Geeta Upadhyay. „Small Molecule Binds with Lymphocyte Antigen 6K to Induce Cancer Cell Death“. Cancers 12, Nr. 2 (22.02.2020): 509. http://dx.doi.org/10.3390/cancers12020509.
Der volle Inhalt der QuelleCalaf, Gloria M., Leodan A. Crispin, Juan P. Muñoz, Francisco Aguayo und Tammy C. Bleak. „Muscarinic Receptors Associated with Cancer“. Cancers 14, Nr. 9 (07.05.2022): 2322. http://dx.doi.org/10.3390/cancers14092322.
Der volle Inhalt der QuelleFerreira, Thamara, Thais Ferreira Bomfim-Palma, Isabelle Joyce de Lima Silva-Fernandes, Gabriela Espirito Santo Felix, Inacelli Queiroz De Souza Caires, Leandro Apolinário Silva, Luciana Garcia Landeiro et al. „PALB2 mutations in Brazilian patients from North-Northeast regions.“ Journal of Clinical Oncology 38, Nr. 15_suppl (20.05.2020): e13670-e13670. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e13670.
Der volle Inhalt der QuelleDUPONT, J., C. AGHAJANIAN, P. SABBATINI und D. R. SPRIGGS. „New agents for the treatment of ovarian cancer: the next generation“. International Journal of Gynecologic Cancer 15, Suppl 3 (November 2005): 252–57. http://dx.doi.org/10.1136/ijgc-00009577-200511001-00012.
Der volle Inhalt der QuelleMuggia, Franco M. „Significant developments in ovarian, breast and lung cancer therapy“. Inpharma Weekly &NA;, Nr. 994 (Juli 1995): 3–5. http://dx.doi.org/10.2165/00128413-199509940-00002.
Der volle Inhalt der QuelleBrown, Geoffrey. „Deregulation of All-Trans Retinoic Acid Signaling and Development in Cancer“. International Journal of Molecular Sciences 24, Nr. 15 (28.07.2023): 12089. http://dx.doi.org/10.3390/ijms241512089.
Der volle Inhalt der QuelleCole, Alexander P., Chang Lu, Marieke J. Krimphove, Julie Szymaniak, Maxine Sun, Sean A. Fletcher, Stuart R. Lipsitz et al. „Comparing the Association Between Insurance and Mortality in Ovarian, Pancreatic, Lung, Colorectal, Prostate, and Breast Cancers“. Journal of the National Comprehensive Cancer Network 17, Nr. 9 (September 2019): 1049–58. http://dx.doi.org/10.6004/jnccn.2019.7296.
Der volle Inhalt der QuelleSolomon, Benjamin Maurice, Kari G. Rabe, Susan L. Slager, Jerry D. Brewer, James R. Cerhan und Tait D. Shanafelt. „Overall and cancer-specific survival of breast, colon, and lung cancer in patients with and without chronic lymphocytic leukemia: A SEER population-based study of over 1 million patients.“ Journal of Clinical Oncology 30, Nr. 15_suppl (20.05.2012): 6571. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.6571.
Der volle Inhalt der QuelleLawler, Thomas, und Shaneda Warren Andersen. „Serum 25-Hydroxyvitamin D and Cancer Risk: A Systematic Review of Mendelian Randomization Studies“. Nutrients 15, Nr. 2 (13.01.2023): 422. http://dx.doi.org/10.3390/nu15020422.
Der volle Inhalt der QuelleGuo, Maoni, und San Ming Wang. „The BRCAness Landscape of Cancer“. Cells 11, Nr. 23 (01.12.2022): 3877. http://dx.doi.org/10.3390/cells11233877.
Der volle Inhalt der QuelleCheng, En, Donghoon Lee, Rulla M. Tamimi, Susan Hankinson, Walter C. Willett, Edward L. Giovannucci, Heather Eliassen et al. „Long-term cancer survival in cohorts of U.S. health professionals.“ Journal of Clinical Oncology 38, Nr. 15_suppl (20.05.2020): 12075. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.12075.
Der volle Inhalt der QuelleTourassi, Georgia, Hong-Jun Yoon, Songhua Xu und Xuesong Han. „The utility of web mining for epidemiological research: studying the association between parity and cancer risk“. Journal of the American Medical Informatics Association 23, Nr. 3 (27.11.2015): 588–95. http://dx.doi.org/10.1093/jamia/ocv141.
Der volle Inhalt der QuelleLuo, Huiyan, Pansong Li, Wei Wei, Yong-Bin Lin, Hong Yang, Han Yang, Kong-Jia Luo et al. „High-sensitive multi-cancers early detection for 8 cancer types by cell-free DNA targeted methylation sequencing: A retrospective cohort study.“ Journal of Clinical Oncology 42, Nr. 16_suppl (01.06.2024): 3043. http://dx.doi.org/10.1200/jco.2024.42.16_suppl.3043.
Der volle Inhalt der QuelleOlea-Flores, Monserrat, Juan C. Juárez-Cruz, Miriam D. Zuñiga-Eulogio, Erika Acosta, Eduardo García-Rodríguez, Ana E. Zacapala-Gomez, Miguel A. Mendoza-Catalán, Julio Ortiz-Ortiz, Carlos Ortuño-Pineda und Napoleón Navarro-Tito. „New Actors Driving the Epithelial–Mesenchymal Transition in Cancer: The Role of Leptin“. Biomolecules 10, Nr. 12 (15.12.2020): 1676. http://dx.doi.org/10.3390/biom10121676.
Der volle Inhalt der QuelleBacalbasa, N., A. Traistaru und I. Balescu. „OVARIAN METASTATIC TUMORS – A LITERATURE REVIEW“. Romanian Medical Journal 62, Nr. 2 (30.06.2015): 115–18. http://dx.doi.org/10.37897/rmj.2015.2.6.
Der volle Inhalt der QuelleAdeboyeje, Gboyega, Eleanor O. Caplan, Yihua Xu, Monica Chase, Sheetal Sheth, Brandon T. Suehs und Nicole Myer. „Abstract 4111: Trends in the use of broad genomic sequencing-directed therapy among Medicare patients with newly diagnosed advanced cancer in the United States from 2018-2020: A retrospective analysis from the SEQUENCE study“. Cancer Research 82, Nr. 12_Supplement (15.06.2022): 4111. http://dx.doi.org/10.1158/1538-7445.am2022-4111.
Der volle Inhalt der QuelleYap, Timothy A., Arya Ashok, Jessica Stoll, Anna Ewa Schwarzbach, Kimberly L. Blackwell, Tianhong Li, Hyunseok Kang, Judy Ellen Garber und Funda Meric-Bernstam. „Rate of incidental germline findings detected by tumor-normal matched sequencing in cancer types lacking hereditary cancer testing guidelines.“ Journal of Clinical Oncology 39, Nr. 15_suppl (20.05.2021): 10582. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.10582.
Der volle Inhalt der QuelleVlasenkova, Ramilia, Alsina Nurgalieva, Natalia Akberova, Mikhail Bogdanov und Ramziya Kiyamova. „Characterization of SLC34A2 as a Potential Prognostic Marker of Oncological Diseases“. Biomolecules 11, Nr. 12 (14.12.2021): 1878. http://dx.doi.org/10.3390/biom11121878.
Der volle Inhalt der QuelleAtta, Ihab Shafek, und Fahd Nasser AlQahtani. „Thyroid, Renal, and Breast Carcinomas, Chondrosarcoma, Colon Adenomas, and Ganglioneuroma: A New Cancer Syndrome, FAP, or Just Coincidence“. Case Reports in Medicine 2016 (2016): 1–5. http://dx.doi.org/10.1155/2016/2928084.
Der volle Inhalt der QuelleHeeke, Arielle Lutterman, Tabari Baker, Filipa Lynce, Michael J. Pishvaian und Claudine Isaacs. „Prevalence of homologous recombination deficiency among all tumor types.“ Journal of Clinical Oncology 35, Nr. 15_suppl (20.05.2017): 1502. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.1502.
Der volle Inhalt der QuelleBel’skaya, Lyudmila V., Elena A. Sarf, Alexandra I. Loginova, Dmitry M. Vyushkov und En Djun Choi. „Potential Diagnostic Value of Salivary Tumor Markers in Breast, Lung and Ovarian Cancer: A Preliminary Study“. Current Issues in Molecular Biology 45, Nr. 6 (10.06.2023): 5084–98. http://dx.doi.org/10.3390/cimb45060323.
Der volle Inhalt der QuelleChen, Lifeng, Binbing Ling, Jane Alcorn und Jian Yang. „Quantitative Analysis of the Expression of Human N-myristoyltransferase 1 (hNMT-1) in Cancers“. Open Biomarkers Journal 2, Nr. 1 (13.03.2009): 6–10. http://dx.doi.org/10.2174/1875318300902010006.
Der volle Inhalt der QuelleCuriel, Tyler, Suzanne Thibodeaux, Shawna Wall, Sri Lakshmi Pandeswara, Benjamin Daniel, Justin Drerup, Kruthi Murthy, Ilona Kryczek, Weiping Zou und Brian Barnett. „Denileukin diftitox depletes regulatory T cells without clinical benefit in advanced stage epithelial ovarian carcinoma (VAC3P.945)“. Journal of Immunology 192, Nr. 1_Supplement (01.05.2014): 73.7. http://dx.doi.org/10.4049/jimmunol.192.supp.73.7.
Der volle Inhalt der QuelleDetopoulou, Paraskevi, George I. Panoutsopoulos, Marina Mantoglou, Periklis Michailidis, Ifigenia Pantazi, Spyros Papadopoulos und Andrea Paola Rojas Gil. „Relation of Mean Platelet Volume (MPV) with Cancer: A Systematic Review with a Focus on Disease Outcome on Twelve Types of Cancer“. Current Oncology 30, Nr. 3 (14.03.2023): 3391–420. http://dx.doi.org/10.3390/curroncol30030258.
Der volle Inhalt der QuelleChoi, Eunji, Justin Lee, Julie T. Wu, Heather A. Wakelee, Lidia Schapira, Allison W. Kurian und Summer S. Han. „Abstract P055: Risk factors for second primary lung cancer among breast cancer survivors“. Cancer Prevention Research 16, Nr. 1_Supplement (01.01.2023): P055. http://dx.doi.org/10.1158/1940-6215.precprev22-p055.
Der volle Inhalt der QuelleSah, Sunil Kumar, Naval Kishor Yadav, Roshan Kurmi, Ramanuj Rauniyar, Krishan Das Manandhar und Birendra Prasad Gupta. „Pattern of Cancer in Nepal from 2003 to 2011“. Nepal Journal of Biotechnology 4, Nr. 1 (31.12.2016): 54–60. http://dx.doi.org/10.3126/njb.v4i1.16348.
Der volle Inhalt der QuelleLindsay, Colin R., Emily C. Shaw, Fiona Blackhall, Kevin G. Blyth, James D. Brenton, Anshuman Chaturvedi, Noel Clarke et al. „Somatic cancer genetics in the UK: real-world data from phase I of the Cancer Research UK Stratified Medicine Programme“. ESMO Open 3, Nr. 6 (September 2018): e000408. http://dx.doi.org/10.1136/esmoopen-2018-000408.
Der volle Inhalt der QuelleSun, Ming-Yang, Chia-Lun Chang, Chang-Yun Lu, Szu-Yuan Wu und Jia-Qiang Zhang. „Sarcopenia as an Independent Risk Factor for Specific Cancers: A Propensity Score-Matched Asian Population-Based Cohort Study“. Nutrients 14, Nr. 9 (02.05.2022): 1910. http://dx.doi.org/10.3390/nu14091910.
Der volle Inhalt der QuelleMetzen, Marlon, Michael Bruns, Wolfgang Deppert und Udo Schumacher. „Infiltration of Immune Competent Cells into Primary Tumors and Their Surrounding Connective Tissues in Xenograft and Syngeneic Mouse Models“. International Journal of Molecular Sciences 22, Nr. 8 (19.04.2021): 4213. http://dx.doi.org/10.3390/ijms22084213.
Der volle Inhalt der QuelleKawashiri, Takehiro, Daisuke Kobayashi, Mayako Uchida, Shiori Hiromoto, Masashi Inoue, Hajime Ikeda, Mizuki Inoue und Takao Shimazoe. „Analysis of Secondary Leukemia and Myelodysplastic Syndrome After Chemotherapy for Solid Organ Tumors Using the Food and Drug Administration Adverse Event Reporting System (FAERS)“. Journal of Pharmacy & Pharmaceutical Sciences 24 (11.10.2021): 499–508. http://dx.doi.org/10.18433/jpps31862.
Der volle Inhalt der Quelle